EL7.AI
StocksMedium•5 August 2026•
1 min read

AdaptHealth Shares Plunge on Q2 Loss and Diabetes Unit Sale to Cardinal Health

Key Facts

1AdaptHealth reported a $1.07 per share loss in Q2 with a revenue miss of $106 million against expectations.
2AdaptHealth agreed to sell its diabetes business to Cardinal Health for $235 million.
3The company slashed EBITDA guidance by $160 million due to the impact of new fixed-price contracts.

In a move reflecting mounting operational challenges in the healthcare sector, AdaptHealth shares plunged following the release of Q2 results that significantly missed market expectations. The company reported a substantial net loss of $1.07 per share, alongside a revenue shortfall of $106 million against analyst forecasts. This downturn was primarily driven by the adverse impact of new fixed-price contracts, leading the company to announce its exit from the diabetes segment.

As part of a strategic restructuring, AdaptHealth has agreed to divest its diabetes business to Cardinal Health for $235 million. This decision comes as the company faces severe margin compression, resulting in a $160 million downward revision to its EBITDA guidance. According to reports, new fixed-price contracts on the West Coast alone contributed a $55 million negative hit to the company's financial performance.

Investors are monitoring broader economic catalysts following the Fed Interest Rate Decision on July 29, 2026, which held rates at 3.75%, as the company navigates its strategic pivot and guidance adjustments.